Immunomodulatory Agents for Multiple Myeloma.

Published in: Cancers (2022)

The treatment of multiple myeloma (MM) has undergone a significant paradigm shift in the last 20 years, from conventional chemotherapy to more tumor-specific treatments, based on the interference with pathogenesis of the malignant clone as well as the bone microenvironment [...].

Keyphrases

multiple myeloma
stem cells
bone mineral density
locally advanced
radiation therapy
combination therapy
bone loss
postmenopausal women